女性在心血管临床试验领导力中的代表性。
Representation of Women in Cardiovascular Clinical Trial Leadership.
机构信息
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
JAMA Intern Med. 2020 Oct 1;180(10):1382-1383. doi: 10.1001/jamainternmed.2020.2485.
Abstract
This quality improvement study describes representation of women within leadership committees of clinical trials and in lead authorship positions of ensuing cardiovascular trial publications.
摘要
本质量改进研究描述了临床试验领导委员会中的女性代表情况，以及随后心血管试验出版物的主要作者职位中的女性代表情况。
相似文献
1
Representation of Women in Cardiovascular Clinical Trial Leadership.女性在心血管临床试验领导力中的代表性。
JAMA Intern Med. 2020 Oct 1;180(10):1382-1383. doi: 10.1001/jamainternmed.2020.2485.
2
Gender Differences in the Professional Lives of Cardiologists in 70 Spanish Hospitals.西班牙70家医院心脏病专家职业生活中的性别差异
Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):272-274. doi: 10.1016/j.rec.2018.08.013. Epub 2018 Sep 20.
3
Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials.妇科肿瘤学 3 期临床试验中女性主要研究者（PI）的代表性趋势和地域差异。
Gynecol Oncol. 2021 Aug;162(2):389-393. doi: 10.1016/j.ygyno.2021.05.037. Epub 2021 Jun 5.
4
Is There a Gender Gap in Spanish Cardiology?西班牙心脏病学领域存在性别差距吗？
Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):195-197. doi: 10.1016/j.rec.2018.07.023. Epub 2018 Nov 15.
5
Effect of Treatment by Female Cardiologists on Short-Term Readmission Rates of Patients Hospitalized With Cardiovascular Diseases.女性心内科医生治疗对心血管疾病住院患者短期再入院率的影响。
Circ J. 2019 Aug 23;83(9):1937-1943. doi: 10.1253/circj.CJ-19-0357. Epub 2019 Jul 27.
6
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week.终结心血管临床试验领导力中的性别不平等：《美国心脏病学会杂志》专题周评。
J Am Coll Cardiol. 2021 Jun 15;77(23):2960-2972. doi: 10.1016/j.jacc.2021.04.038.
7
Research leadership and investigators: gender distribution in the federal government.研究领导和研究人员：联邦政府中的性别分布。
Am J Med. 2012 Aug;125(8):811-6. doi: 10.1016/j.amjmed.2012.03.006. Epub 2012 May 10.
8
Women in Interventional Cardiology: Past, Present, and Future-Small Numbers, Growing Impact.介入心脏病学领域的女性：过去、现在与未来——人数虽少，影响日增。
JACC Cardiovasc Interv. 2018 Jan 8;11(1):104-106. doi: 10.1016/j.jcin.2017.11.027.
9
Six percent of electrophysiology operators in the United States are women: Are we making enough progress?在美国，6%的电生理操作员是女性：我们是否取得了足够的进展？
Heart Rhythm. 2022 May;19(5):812-813. doi: 10.1016/j.hrthm.2022.02.023.
10
The representation of women on the editorial boards of major medical journals: a 35-year perspective.主要医学期刊编辑委员会中女性的代表性：35年的视角
Arch Intern Med. 2008 Mar 10;168(5):544-8. doi: 10.1001/archinte.168.5.544.
引用本文的文献
1
Participation of Women in Cardiovascular Trials From 2017 to 2023: A Systematic Review.2017年至2023年女性参与心血管试验情况：一项系统评价
JAMA Netw Open. 2025 Aug 1;8(8):e2529104. doi: 10.1001/jamanetworkopen.2025.29104.
2
Gender Differences in X (Formerly Twitter) Use, Influence, and Engagement Among Cardiologists From the Top U.S. News Best Hospitals.美国新闻周刊最佳医院中，心脏病专家在X（原推特）使用、影响力和参与度方面的性别差异。
JMIR Cardio. 2025 Jun 4;9:e66308. doi: 10.2196/66308.
3
Cultivating a thriving environment for women in cardiology through leadership and inclusion.通过领导力和包容性为女性营造一个蓬勃发展的心脏病学环境。
Am Heart J Plus. 2025 Jan 15;50:100500. doi: 10.1016/j.ahjo.2025.100500. eCollection 2025 Feb.
4
Sex Differences in the Participation in Secondary Prevention Stroke Studies.二级预防中风研究参与情况中的性别差异。
J Am Heart Assoc. 2025 Mar 4;14(5):e038917. doi: 10.1161/JAHA.124.038917. Epub 2025 Feb 25.
5
Global perspectives to enhance strategies for advancing women in healthcare and STEMM leadership.提升女性在医疗保健和STEMM领域领导力的战略的全球视角。
Immunol Cell Biol. 2025 Mar;103(3):234-250. doi: 10.1111/imcb.12854. Epub 2025 Feb 5.
6
Are females in classical hematology getting a fair share? Uncovering gender disparities in NIH R01 grants.在经典血液学领域，女性是否得到了公平的份额？揭示美国国立卫生研究院R01基金中的性别差异。
Front Sociol. 2024 Nov 18;9:1430369. doi: 10.3389/fsoc.2024.1430369. eCollection 2024.
7
Underrepresentation of women in cardiovascular disease clinical Trials-What's in a Name?心血管疾病临床试验中女性受试者代表性不足——名称有何含义？
Int J Cardiol Heart Vasc. 2024 Nov 8;55:101547. doi: 10.1016/j.ijcha.2024.101547. eCollection 2024 Dec.
8
How to make cardiology clinical trials more inclusive.如何使心脏病学临床试验更具包容性。
Nat Med. 2024 Oct;30(10):2745-2755. doi: 10.1038/s41591-024-03273-3. Epub 2024 Oct 14.
9
Teaching gender medicine can enhance the quality of healthcare.教授性别医学可以提高医疗保健质量。
Am Heart J Plus. 2024 Jun 25;44:100418. doi: 10.1016/j.ahjo.2024.100418. eCollection 2024 Aug.
10
Unique features of dyslipidemia in women across a lifetime and a tailored approach to management.女性一生中血脂异常的独特特征及个性化管理方法。
Am J Prev Cardiol. 2024 Apr 5;18:100666. doi: 10.1016/j.ajpc.2024.100666. eCollection 2024 Jun.
本文引用的文献
1
How do we attract and retain women in cardiology?我们如何吸引并留住从事心脏病学领域工作的女性？
Clin Cardiol. 2018 Feb;41(2):264-268. doi: 10.1002/clc.22921. Epub 2018 Feb 26.
2
Gender-heterogeneous working groups produce higher quality science.性别多元化的工作团队能产出质量更高的科研成果。
PLoS One. 2013 Oct 30;8(10):e79147. doi: 10.1371/journal.pone.0079147. eCollection 2013.
3
The possible role of resource requirements and academic career-choice risk on gender differences in publication rate and impact.资源需求和学术职业选择风险在出版率和影响的性别差异中的可能作用。
PLoS One. 2012;7(12):e51332. doi: 10.1371/journal.pone.0051332. Epub 2012 Dec 12.
4
Falling off the academic bandwagon. Women are more likely to quit at the postdoc to principal investigator transition.跟不上学术潮流。女性在从博士后向首席研究员过渡阶段更有可能退出。
EMBO Rep. 2007 Nov;8(11):977-81. doi: 10.1038/sj.embor.7401110.
Zotero 插件